Levine E A, Gould S A
Department of Surgery, Louisiana State University School of Medicine, New Orleans.
Surg Annu. 1993;25 Pt 1:83-99.
Stimulation of erythropoiesis is an attractive alternative to the risks of homologous transfusion. The availability of rHuEPO has made erythropoietic acceleration possible. The use of rHuEPO perioperatively and in preoperative autologous donation will likely find firm indications. Combinations of present methods of autologous blood use with the various rHuEPO regimens will be the best methods of minimizing perioperative homologous blood exposure.
刺激红细胞生成是一种有吸引力的替代方法，可避免同种异体输血的风险。重组人促红细胞生成素（rHuEPO）的可得性使加速红细胞生成成为可能。围手术期及术前自体献血时使用rHuEPO可能会有明确的适应证。将目前的自体血使用方法与各种rHuEPO方案相结合，将是使围手术期同种异体血暴露降至最低的最佳方法。
